3 ms·
The good part of the answer: Because they need to make sure the treatment doesn't kill more people than the virus does. The bad part of the answer: Overseas
by amalcon 7y ago
The good part of the answer: Because they need to make sure the treatment doesn't kill more people than the virus does.
The bad part of the answer: Overseas testing (e.g. the testing needed for EU approvals) usually does not count for this purpose for bureaucracy reasons.
- gnulinux 7y agoIs there no hope to expedite it in this case? Are we gonna sit and watch dozens, maybe hundreds of Americans dying of a disease that has a medication in EU and China?
- amalcon 7y agoYes, there's hope to expedite it in this case. There are people working on that. The Gates foundation, for one, is funding "development" of treatments per the article[1]. "Development" includes but is not limited to getting regulatory approval as quickly as possible. [1]- I am not affiliated with them in any way, have no specific nonpublic information, and I don't know if they are looking at this specific treatment.